Credence Research Logo

Home » Healthcare » Solid Organ Transplant Immunosuppressants Market

Solid Organ Transplant Immunosuppressants Market By Organ Transplant Type (Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant) By Patient Age (Pediatric Patients, Adult Patients) – Growth, Share, Opportunities & Competitive Analysis, 2018 – 2028

Price: $3699

Published: | Report ID: 22069 | Report Format : PDF

Market Insights

  • The global demand for solid organ transplant immunosuppressants was valued at USD 1.3 billion in 2022 and is expected to reach USD 2.20 billion in 2030, growing at a CAGR of 6.80% between 2023 and 2030.
  • Calcineurin inhibitor is the leading segment by drug class.
  • Kidney transplant is the leading segment by organ transplant type.
  • During the projected period, the category for adult patients is expected to increase at the greatest CAGR.
  • The long-term maintenance treatment segment is predicted to register the greatest CAGR during the forecast period.
  • The retail pharmacies category will be expected to have the highest CAGR throughout the projection period.
  • The intravenous (IV) formulations segment is predicted to register the greatest CAGR during the forecast period.
  • North America dominated the solid organ transplant immunosuppressant market.
  • Europe is anticipated to be the second-largest region in the solid organ transplant immunosuppressant market.
  • The region of Asia Pacific is anticipated to experience the fastest growth in the solid organ transplant immunosuppressant market.
  • The solid organ transplant immunosuppressant market is expanding for several reasons, including rising organ transplantation rates, improvements in transplantation techniques, an aging population, and patient support initiatives.
  • Acceptance of patient-centered treatment models, improvements in the field of regenerative medicine, and rising telehealth and distant monitoring technology use are the most important growth potentials for the solid organ transplant immunosuppressant industry.

Executive Summary

Market Definition

The pharmaceutical and healthcare industry segment that focuses on discovering, manufacturing, distributing, and using immunosuppressive treatments or pharmaceuticals is known as the “Solid Organ Transplant Immunosuppressant Market.” These drugs are primarily used to stop the recipient’s immune system from rejecting a transplanted solid organ such as the heart, kidney, liver, lung, or pancreas. Solid organ transplantation is a life-saving medical surgery. Still, it carries the danger of rejection when the recipient’s immune system perceives the transplanted organ as foreign and produces an immune reaction to assault it.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Overview

The market for solid organ transplant immunosuppressants has been expanding steadily in recent years, and between 2023 and 2030, it is anticipated to rise at a CAGR of 6.80%. The market was estimated to be worth USD 1.3 billion in 2022 and is anticipated to be worth USD 2.20 billion in 2030.

Increasing organ transplantation rates, advancements in transplantation procedures, a growing aging population, and patient support programs are some of the major reasons boosting the growth of the solid organ transplant immunosuppressant market. Organ transplantation is more frequently needed due to the aging population’s increased risk of chronic illnesses and organ failure. Immunosuppressive medications are more necessary as lifespans increase to sustain graft function over time.

Researchers and healthcare professionals are studying immunosuppression minimization techniques, which seek to reduce the overall load of immunosuppressant drugs while maintaining graft function and minimizing adverse effects. Innovation opportunity exists in striking the optimal balance between efficient immunosuppression and reduced drug exposure.

The main opportunities to expand the solid organ transplant immunosuppressant market are the adoption of patient-centered care models, the growing use of telehealth and remote monitoring technology and advancements in regenerative medicine.

Segmentation by Drug Class

  • The industry leader among drug classes is the calcineurin inhibitor. Tacrolimus and cyclosporine are two common calcineurin inhibitors to stop kidney transplant rejection. They are frequently taken in addition to other immunosuppressant medications.
  • The antiproliferative agents segment is anticipated to grow significantly during the projection period. Chemotherapy often uses antiproliferative drugs to attack quickly proliferating cancer cells. These substances interfere with the cell cycle and stop the division and growth of cancer cells. Methotrexate, 5-fluorouracil (5-FU), and gemcitabine are a few examples.
  • Other drug classes, such as mTOR inhibitors, corticosteroids, and induction agents, also contribute to the demand for solid organ transplant immunosuppressants.

Segmentation by Organ Transplant Type

  • Organ transplant types are dominated by kidney transplants. The frequency of kidney illnesses and disorders that cause end-stage renal disease (ESRD) are directly correlated with the demand for kidney transplantation. Kidney failure can be brought on by conditions such as diabetes, hypertension, glomerulonephritis, and polycystic kidney disease, which raises the need for organs suitable for donation.
  • The liver transplant category is expected to grow significantly during the forecast period. Alcohol use can result in cirrhosis and liver damage. The need for liver transplantation can change depending on changes in alcohol consumption patterns and the prevalence of alcohol-related liver disease.
  • Other organ transplant types, such as heart, lung, and pancreas transplants, also contribute to the demand for solid organ transplant immunosuppressants.

Segmentation by Patient Age

  • The category for adult patients is anticipated to experience the highest CAGR growth during the anticipated time frame. Immunosuppressive drugs are essential in treating adult patients who have received solid organ transplants. These drugs aid in preventing the immune system of the recipient from labeling the transplanted organ as foreign and attacking it, a condition known as rejection. To ensure the long-term success of the transplant, immunosuppression is a crucial part of post-transplant therapy.
  • Other patient ages, such as pediatric patients, also contribute to the demand for solid organ transplant immunosuppressants.

Segmentation by Treatment Duration

  • The segment for long-term maintenance treatments is anticipated to experience the highest CAGR throughout the forecast period. Long-term maintenance immunosuppression’s major objective is to stop the recipient’s immune system from rejecting the transplanted organ by labeling it as alien and attacking it. To increase the lifespan of the graft, maintenance therapy tries to maintain the transplanted organ in peak condition.
  • Other treatment durations, such as short-term treatment (induction phase), also contribute to the demand for solid organ transplant immunosuppressants.

Segmentation by Distribution Channels

  • Retail pharmacies have the highest CAGR during the forecast time frame. Most of the population may easily access retail pharmacies because they are extensively dispersed throughout urban, suburban, and rural areas. These pharmacies serve as the main source for the timely delivery of medical supplies to patients.
  • Other distribution channels, such as hospitals, clinics, and specialty pharmacies, also contribute to the demand for solid organ transplant immunosuppressants.

Segmentation by Dosage Forms

  • The market segment for intravenous (IV) formulations is anticipated to grow at the highest CAGR in the forecast period. In emergency and critical care settings, IV medicines are often used when prompt and accurate drug delivery is required. They are essential for preserving the health of patients with serious medical disorders.
  • Other dosage forms, such as oral tablets/capsules, also contribute to solid organ transplant immunosuppressant demand.

Segmentation by Region

  • The solid organ transplant immunosuppressant market is largely dominated by North America. The use of personalized medicine in transplantation grew in popularity in North America. To maximize therapeutic effectiveness and lessen adverse effects, healthcare professionals are increasingly customizing immunosuppressant regimens based on unique patient features, such as genetics, metabolism, and immunological response.
  • It is expected that Europe will rank second in the global market for solid organ transplant immunosuppressants.
  • The solid organ transplant immunosuppressant industry is expected to develop at the fastest rate in Asia Pacific.
  • The rest of the demand for solid organ transplant immunosuppressants is met by the rest of the world, which includes Latin America, the Middle East, and Africa.

The solid organ transplant immunosuppressant market is expanding for several key reasons, including rising organ transplantation rates, improvements in transplantation techniques, an aging population, and patient support initiatives.

The North American region will dominate the solid organ transplant immunosuppressant market throughout the forecast period. The frequency of solid organ transplants has steadily increased in North America as a result of improvements in post-transplant care, transplantation techniques, and public awareness of organ donation. This pattern has a direct impact on the demand for immunosuppressive drugs. Inducing immunological tolerance in transplant recipients without the requirement for lifelong immunosuppression is the subject of an ongoing study in North America. The development of patience would be a major step forward for transplant medicine. Based on patients’ genetic profiles, immunosuppressant drug selection and dose in North America were being improved by pharmacogenomic research.

Asia Pacific is expected to increase fastest during the projection period. The COVID-19 pandemic increased the uptake of telehealth and remote monitoring uptake in the Asia Pacific area, as in other regions. Remote medication management and follow-up treatment have assisted transplant recipients. Organ transplants and other forms of medical tourism are increasingly common in some nations in the Asia-Pacific area. This has increased the demand for transplant surgeries and associated drugs.

India’s pharmaceutical sector is booming and can create a variety of generic immunosuppressants. This helps make these medications more widely available and more reasonably priced.

Hospitals and healthcare organizations in India are increasingly offering patient support initiatives for transplant recipients. These initiatives provide counseling, education, and support for drug adherence.

Key Highlights of the Report

The global solid organ transplant immunosuppressant market is segmented by drug class, organ transplant type, patient age, treatment duration, distribution channels, dosage forms, and region. The leading drug class by segment is calcineurin inhibitors. By organ transplant type, kidney transplants are the most common. The category for adult patients is expected to grow at the highest CAGR in the forecast period. The category that will experience the highest CAGR during the forecast period is long-term maintenance treatments. North America is driving the solid organ transplant immunosuppressant market growth.

The global market for solid organ transplant immunosuppressants is increasing for several causes, including expanding organ transplantation rates, improvements in transplantation methods, an aging population, and patient support schemes. The main opportunities to expand the solid organ transplant immunosuppressant market are the adoption of patient-centered care models, advancements in regenerative medicine, and the remote monitoring technology and growing use of telehealth.

However, North America is predicted to hold the largest market share for solid organ transplant immunosuppressants globally. Improvements in post-transplant care, transplantation methods, and public awareness of donating organs have led to a steady rise in the number of solid organ transplants in North America. The need for immunosuppressive medications is directly impacted by this phenomenon. Moreover, the market expands at the highest rate in the Asia-Pacific (APAC) region. Organ transplants and other types of medical tourism are becoming more and more popular in various countries in the Asia-Pacific region. Due to this, there is now more demand for medications and transplant surgeries.

What Are the Main Factors Driving the Solid Organ Transplant Immunosuppressant Market Globally?

Advancements in transplantation procedures, increasing organ transplantation rates, a growing aging population, and patient support programs are some of the major reasons boosting the growth of the solid organ transplant immunosuppressant market.

What Are The Main Challenges In The Global Solid Organ Transplant Immunosuppressant Market?

Organ scarcity, immunosuppression-related problems, medication non-adherence, immunological difficulties, and immunosuppressant drug expense are restraining the growth of the solid organ transplant immunosuppressant market.

What Market Opportunities Exist For Solid Organ Transplant Immunosuppressant Globally?

As the solid organ transplant immunosuppressant market expands, new patient-centered care models, regenerative medicine advances, and telehealth & remote monitoring technologies become more prevalent; three main opportunities present themselves.

Market Drivers

Several factors influence the global market for solid organ transplant immunosuppressants. The following are the main global market drivers for solid organ transplant immunosuppressants:

Increasing Organ Transplantation Rates

Solid organ transplant immunosuppressant industry development is significantly influenced by widening organ transplantation incidence. Together with the increase in organ transplant surgeries comes an increased requirement for immunosuppressant medications. These drugs are crucial to post-transplant care because they help keep the immune system of the patient from discarding the given organ. As a result, there is a clear correlation between the rise in transplantations and the demand for immunosuppressant medications. The number of patients needing immunosuppressant therapy has increased as more people obtain organ transplants. This includes patients undergoing kidney, heart, liver, lung, pancreatic, and other solid organ transplants. To further preserve the function of their transplanted organs, these transplant patients frequently require a long time of immunosuppression.

Variables like medical facilities, public awareness, and legal frameworks can be used to explain regional and national variations in the increase in organ transplantation frequencies. In regions where transplantation rates are rising, there will likely be an increase in the demand for immunosuppressants.

Market Restraints

Several challenges may arise when the solid organ transplant immunosuppressant sector expands globally. These are a few of them:

High Costs Of The Immunosuppressant Drugs

Immunosuppressant medication costs can be a significant financial burden for transplant patients, particularly when they are required long-term. The cost of these medications may be prohibitive for many people and families, resulting in non-adherence or postponed treatment. Access to transplantation and post-transplant therapy may be hampered by high drug costs, especially for those without appropriate health insurance. Lower-income people or those without insurance may be disproportionately affected, leading to inequities in access to transplantation services.

The high cost of immunosuppressant medications can strain the finances of healthcare systems and insurance companies. This may make allocating resources difficult and impact choices made about transplant policies and initiatives.

Opportunities

The global industry offers multiple opportunities for solid organ transplant immunosuppressants. One of these is demonstrated here:

R&D in Solid Organ Transplant Immunosuppressant

For the market to experience significant growth, research and development (R&D) in immunosuppressants for solid organ transplants is essential. These opportunities result from improvements in treatment outcomes, drug development advances, and tackling current issues. Research and development initiatives can result in the discovery and creation of novel immunosuppressant medications with enhanced efficacy, safety profiles, and mechanisms of action. These new drugs may improve transplantation outcomes and have fewer side effects, increasing their uptake. Research and development can concentrate on reducing immunosuppressant medication side effects. Transplant recipients are more likely to be administered and take medications with fewer side effects, which improves overall patient care.

In conclusion, solid R&D activities in solid organ transplant immunosuppressants can spur market expansion by enhancing available treatments, patient outcomes, and the general standard of care for transplant patients. These developments benefit patients and help the market remain viable and grow.

Competitive Landscape

Key Players

Many large companies are actively involved in the global solid organ transplant immunosuppressant market. The top market participants and their corresponding market shares are listed in the list below:

  • Novartis
  • Wyeth (Pfizer)
  • Genzyme (Sanofi)
  • Roche
  • Astellas Pharma
  • GlaxoSmithKline
  • Bristol-Myers Squibb Company
  • Veloxis Pharmaceuticals A/S
  • Belcher Pharmaceuticals LLC
  • Mylan Laboratories, Inc.

To stay competitive, these businesses prioritize mergers and acquisitions, distribution channel development, and product innovation.

The top competitors in the global solid organ transplant immunosuppressant market constantly seek to gain an advantage by releasing new products and innovations.

In August 2022, India-based Concord Biotech Limited submitted its Draught Red Herring Prospectus (DRHP) to Securities and Exchange Board of India (SEBI), the country’s market watchdog, in order to acquire capital through an initial public offering (IPO). In terms of share in the market based on volume in 2021, Concord Biotech Limited is one of the creators and producers of certain fermentation-based APIs spanning immunosuppressants and cancer.

In August 2022, Strides’ Cyclosporine Softgel Capsules gained USFDA certification. With the addition of Tacrolimus capsules, Cyclosporine Softgel capsules, and Mycophenolate Mofetil tablets and capsules to its range of immunosuppressant products for the US market, Strides further solidified its position in the market.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Summary of Key Findings

  • Solid organ transplant immunosuppressant industry growth is influenced by a number of factors, which involve rising organ transplantation rates, improvements in transplanting techniques, an aging population, and patient support campaigns.
  • Market segmented by drug class, organ transplant type, patient age, treatment duration, distribution channels, dosage forms, and region.
  • The market leader among the drug class is the calcineurin inhibitor.
  • When it comes to organ transplant types, kidney transplants are in the lead.
  • During the projected period, the adult patients category is expected to increase at the greatest CAGR.
  • The long-term maintenance treatment segment is anticipated to register the greatest CAGR during the forecast period.
  • North America is leading market growth; the market is highly competitive with key players including Novartis, Wyeth (Pfizer), Genzyme (Sanofi), Roche, Astellas Pharma, GlaxoSmithKline, Bristol-Myers Squibb Company, Veloxis Pharmaceuticals A/S, Belcher Pharmaceuticals LLC, Mylan Laboratories, Inc., and others.

Future Outlook

  • Positive outlook for the global solid organ transplant immunosuppressant market with significant growth potential in the North American region.
  • A major factor in the growth of the solid organ transplant immunosuppressant market is an increase in the number of organ transplantations.
  • During the projection period, organ scarcity could pose a significant challenge to the market’s expansion.
  • Major companies must concentrate on product innovation, expanding their market reach, and maintaining competitive pricing to stay ahead.

Segmentation

  • By Drug Class
    • Calcineurin Inhibitors
      • Cyclosporine
      • Tacrolimus
    • Antiproliferative Agents
      • Mycophenolate Mofetil
      • Azathioprine
    • mTOR Inhibitors
      • Sirolimus (Rapamycin)
      • Everolimus
    • Corticosteroids
    • Induction Agents
      • Basiliximab
      • Daclizumab
      • Alemtuzumab
    • By Organ Transplant Type
      • Kidney Transplant
      • Liver Transplant
      • Heart Transplant
      • Lung Transplant
      • Pancreas Transplant
    • By Patient Age
      • Pediatric Patients
      • Adult Patients
    • By Treatment Duration
      • Short-Term Treatment (Induction Phase)
      • Long-Term Maintenance Treatment
    • By Distribution Channels
      • Hospitals and Clinics
      • Retail Pharmacies
      • Specialty Pharmacies
    • By Dosage Forms
      • Oral Tablets/Capsules
      • Intravenous (IV) Formulations
    • By Region
      • North America
        • The US.
        • Canada
        • Mexico
      • Europe
        • Germany
        • France
        • The U.K.
        • Italy
        • Spain
        • Rest of Europe
      • Asia Pacific
        • China
        • Japan
        • India
        • South Korea
        • South-east Asia
        • Rest of Asia Pacific
      • Latin America
        • Brazil
        • Argentina
        • Rest of Latin America
      • Middle East & Africa
        • GCC Countries
        • South Africa
        • Rest of the Middle East and Africa

Adjacent Markets

The solid organ transplant immunosuppressant industry has several linked markets with high potential for revenue growth. The major markets adjacent to the solid organ transplant immunosuppressant market –

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction

2. Executive Summary
2.1. Market Snapshot: Global Solid Organ Transplant Immunosuppressant Market
2.1.1. Global Solid Organ Transplant Immunosuppressant Market, By Drug Class
2.1.2. Global Solid Organ Transplant Immunosuppressant Market, By Organ Transplant Type
2.1.3. Global Solid Organ Transplant Immunosuppressant Market, By Patient Age
2.1.4. Global Solid Organ Transplant Immunosuppressant Market, By Treatment Duration
2.1.5. Global Solid Organ Transplant Immunosuppressant Market, By Distribution Channels
2.1.6. Global Solid Organ Transplant Immunosuppressant Market, By Dosage Forms
2.1.7. Global Solid Organ Transplant Immunosuppressant Market, By Region
2.2. Insights from Primary Respondents

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Solid Organ Transplant Immunosuppressant Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Solid Organ Transplant Immunosuppressant Market Drivers
3.2.2. Solid Organ Transplant Immunosuppressant Market Restraints
3.2.3. Solid Organ Transplant Immunosuppressant Market Opportunities
3.2.4. Major Solid Organ Transplant Immunosuppressant Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Drug Class
3.5.2. Organ Transplant Type
3.5.3. Patient Age
3.5.4. Treatment Duration
3.5.5. Distribution Channels
3.5.6. Dosage Forms
3.5.7. Geography

4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global Solid Organ Transplant Immunosuppressant Market: Company Market Share, Value 2022
4.1.2. Global Solid Organ Transplant Immunosuppressant Market: Top 6 Company Market Share, Value 2022
4.1.3. Global Solid Organ Transplant Immunosuppressant Market: Top 3 Company Market Share, Value 2022
4.2. Global Solid Organ Transplant Immunosuppressant Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Product Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Product Matrix
4.7. Potential for New Players in the Global Solid Organ Transplant Immunosuppressant Market

5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Treatment Duration Analysis
5.6.1. Research and development in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis

6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Product Launch
6.5.5. Geographical Expansion
6.5.6. Others

7. Impact Analysis of COVID 19 and Russia – Ukraine War on Solid Organ Transplant Immunosuppressant Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Product Mix
7.2.4. Reduced Industrial Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa

8. Global Solid Organ Transplant Immunosuppressant Market, By Drug Class
8.1. Global Solid Organ Transplant Immunosuppressant Market Overview, by Drug Class
8.1.1. Global Solid Organ Transplant Immunosuppressant Market Revenue Share, By Drug Class, 2022 Vs 2030 (in %)
8.2. Calcineurin Inhibitors
8.2.1. Global Solid Organ Transplant Immunosuppressant Market, By Calcineurin Inhibitors, By Region, 2017-2030 (US$ Bn)
8.2.2. Market Dynamics for Calcineurin Inhibitors
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Antiproliferative Agents
8.3.1. Global Solid Organ Transplant Immunosuppressant Market, By Antiproliferative Agents, By Region, 2017-2030 (US$ Bn)
8.3.2. Market Dynamics for Antiproliferative Agents
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
8.4. mTOR Inhibitors
8.4.1. Global Solid Organ Transplant Immunosuppressant Market, By mTOR Inhibitors, By Region, 2017-2030 (US$ Bn)
8.4.2. Market Dynamics for mTOR Inhibitors
8.4.2.1. Drivers
8.4.2.2. Restraints
8.4.2.3. Opportunities
8.4.2.4. Trends
8.5. Corticosteroids
8.5.1. Global Solid Organ Transplant Immunosuppressant Market, By Corticosteroids, By Region, 2017-2030 (US$ Bn)
8.5.2. Market Dynamics for Corticosteroids
8.5.2.1. Drivers
8.5.2.2. Restraints
8.5.2.3. Opportunities
8.5.2.4. Trends
8.6. Induction Agents
8.6.1. Global Solid Organ Transplant Immunosuppressant Market, By Induction Agents, By Region, 2017-2030 (US$ Bn)
8.6.2. Market Dynamics for Induction Agents
8.6.2.1. Drivers
8.6.2.2. Restraints
8.6.2.3. Opportunities
8.6.2.4. Trends

9. Global Solid Organ Transplant Immunosuppressant Market, By Organ Transplant Type
9.1. Global Solid Organ Transplant Immunosuppressant Market Overview, by Organ Transplant Type
9.1.1. Global Solid Organ Transplant Immunosuppressant Market Revenue Share, By Organ Transplant Type, 2022 Vs 2030 (in %)
9.2. Kidney Transplant
9.2.1. Global Solid Organ Transplant Immunosuppressant Market, By Kidney Transplant, By Region, 2017-2030 (US$ Bn)
9.2.2. Market Dynamics for Kidney Transplant
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Liver Transplant
9.3.1. Global Solid Organ Transplant Immunosuppressant Market, By Liver Transplant, By Region, 2017-2030 (US$ Bn)
9.3.2. Market Dynamics for Liver Transplant
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
9.4. Heart Transplant
9.4.1. Global Solid Organ Transplant Immunosuppressant Market, By Heart Transplant, By Region, 2017-2030 (US$ Bn)
9.4.2. Market Dynamics for Heart Transplant
9.4.2.1. Drivers
9.4.2.2. Restraints
9.4.2.3. Opportunities
9.4.2.4. Trends
9.5. Lung Transplant
9.5.1. Global Solid Organ Transplant Immunosuppressant Market, By Lung Transplant, By Region, 2017-2030 (US$ Bn)
9.5.2. Market Dynamics for Lung Transplant
9.5.2.1. Drivers
9.5.2.2. Restraints
9.5.2.3. Opportunities
9.5.2.4. Trends
9.6. Pancreas Transplant
9.6.1. Global Solid Organ Transplant Immunosuppressant Market, By Pancreas Transplant, By Region, 2017-2030 (US$ Bn)
9.6.2. Market Dynamics for Pancreas Transplant
9.6.2.1. Drivers
9.6.2.2. Restraints
9.6.2.3. Opportunities
9.6.2.4. Trends

10. Global Solid Organ Transplant Immunosuppressant Market, By Patient Age
10.1. Global Solid Organ Transplant Immunosuppressant Market Overview, by Patient Age
10.1.1. Global Solid Organ Transplant Immunosuppressant Market Revenue Share, By Patient Age, 2022 Vs 2030 (in %)
10.2. Pediatric Patients
10.2.1. Global Solid Organ Transplant Immunosuppressant Market, By Pediatric Patients, By Region, 2017-2030 (US$ Bn)
10.2.2. Market Dynamics for Pediatric Patients
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Adult Patients
10.3.1. Global Solid Organ Transplant Immunosuppressant Market, By Adult Patients, By Region, 2017-2030 (US$ Bn)
10.3.2. Market Dynamics for Adult Patients
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends

11. Global Solid Organ Transplant Immunosuppressant Market, By Treatment Duration
11.1. Global Solid Organ Transplant Immunosuppressant Market Overview, by Treatment Duration
11.1.1. Global Solid Organ Transplant Immunosuppressant Market Revenue Share, By Treatment Duration, 2022 Vs 2030 (in %)
11.2. Short-Term Treatment (Induction Phase)
11.2.1. Global Solid Organ Transplant Immunosuppressant Market, By Short-Term Treatment (Induction Phase), By Region, 2017-2030 (US$ Bn)
11.2.2. Market Dynamics for Short-Term Treatment (Induction Phase)
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Long-Term Maintenance Treatment
11.3.1. Global Solid Organ Transplant Immunosuppressant Market, By Long-Term Maintenance Treatment, By Region, 2017-2030 (US$ Bn)
11.3.2. Market Dynamics for Long-Term Maintenance Treatment
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends

12. Global Solid Organ Transplant Immunosuppressant Market, By Distribution Channels
12.1. Global Solid Organ Transplant Immunosuppressant Market Overview, by Distribution Channels
12.1.1. Global Solid Organ Transplant Immunosuppressant Market Revenue Share, By Distribution Channels, 2022 Vs 2030 (in %)
12.2. Hospitals and Clinics
12.2.1. Global Solid Organ Transplant Immunosuppressant Market, By Hospitals and Clinics, By Region, 2017-2030 (US$ Bn)
12.2.2. Market Dynamics for Hospitals and Clinics
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Retail Pharmacies
12.3.1. Global Solid Organ Transplant Immunosuppressant Market, By Retail Pharmacies, By Region, 2017-2030 (US$ Bn)
12.3.2. Market Dynamics for Retail Pharmacies
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
12.4. Specialty Pharmacies
12.4.1. Global Solid Organ Transplant Immunosuppressant Market, By Specialty Pharmacies, By Region, 2017-2030 (US$ Bn)
12.4.2. Market Dynamics for Specialty Pharmacies
12.4.2.1. Drivers
12.4.2.2. Restraints
12.4.2.3. Opportunities
12.4.2.4. Trends

13. Global Solid Organ Transplant Immunosuppressant Market, By Dosage Forms
13.1. Global Solid Organ Transplant Immunosuppressant Market Overview, by Dosage Forms
13.1.1. Global Solid Organ Transplant Immunosuppressant Market Revenue Share, By Dosage Forms, 2022 Vs 2030 (in %)
13.2. Oral Tablets/Capsules
13.2.1. Global Solid Organ Transplant Immunosuppressant Market, By Oral Tablets/Capsules, By Region, 2017-2030 (US$ Bn)
13.2.2. Market Dynamics for Oral Tablets/Capsules
13.2.2.1. Drivers
13.2.2.2. Restraints
13.2.2.3. Opportunities
13.2.2.4. Trends
13.3. Intravenous (IV) Formulations
13.3.1. Global Solid Organ Transplant Immunosuppressant Market, By Intravenous (IV) Formulations, By Region, 2017-2030 (US$ Bn)
13.3.2. Market Dynamics for Intravenous (IV) Formulations
13.3.2.1. Drivers
13.3.2.2. Restraints
13.3.2.3. Opportunities
13.3.2.4. Trends

14. Global Solid Organ Transplant Immunosuppressant Market, By Region
14.1. Global Solid Organ Transplant Immunosuppressant Market Overview, by Region
14.1.1. Global Solid Organ Transplant Immunosuppressant Market, By Region, 2022 vs 2030 (in%)
14.2. Drug Class
14.2.1. Global Solid Organ Transplant Immunosuppressant Market, By Drug Class, 2017-2030 (US$ Bn)
14.3. Organ Transplant Type
14.3.1. Global Solid Organ Transplant Immunosuppressant Market, By Organ Transplant Type, 2017-2030 (US$ Bn)
14.4. Patient Age
14.4.1. Global Solid Organ Transplant Immunosuppressant Market, By Patient Age, 2017-2030 (US$ Bn)
14.5. Treatment Duration
14.5.1. Global Solid Organ Transplant Immunosuppressant Market, By Treatment Duration, 2017-2030 (US$ Bn)
14.6. Distribution Channels
14.6.1. Global Solid Organ Transplant Immunosuppressant Market, By Distribution Channels, 2017-2030 (US$ Bn)
14.7. Dosage Forms
14.7.1. Global Solid Organ Transplant Immunosuppressant Market, By Dosage Forms, 2017-2030 (US$ Bn)

15. North America Solid Organ Transplant Immunosuppressant Market Analysis
15.1. Overview
15.1.1. Market Dynamics for North America
15.1.1.1. Drivers
15.1.1.2. Restraints
15.1.1.3. Opportunities
15.1.1.4. Trends
15.2. North America Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2030(US$ Bn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. North America Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2030(US$ Bn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. North America Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2030(US$ Bn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. North America Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2030(US$ Bn)
15.5.1. Overview
15.5.2. SRC Analysis
15.6. North America Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2030(US$ Bn)
15.6.1. Overview
15.6.2. SRC Analysis
15.7. North America Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2030(US$ Bn)
15.7.1. Overview
15.7.2. SRC Analysis
15.8. North America Solid Organ Transplant Immunosuppressant Market, by Country, 2017-2030 (US$ Bn)
15.8.1. North America Solid Organ Transplant Immunosuppressant Market, by Country, 2022 Vs 2030 (in%)
15.8.2. U.S.
15.8.3. Canada
15.8.4. Mexico

16. Europe Solid Organ Transplant Immunosuppressant Market Analysis
16.1. Overview
16.1.1. Market Dynamics for Europe
16.1.1.1. Drivers
16.1.1.2. Restraints
16.1.1.3. Opportunities
16.1.1.4. Trends
16.2. Europe Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2030(US$ Bn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Europe Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2030(US$ Bn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Europe Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2030(US$ Bn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Europe Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2030(US$ Bn)
16.5.1. Overview
16.5.2. SRC Analysis
16.6. Europe Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2030(US$ Bn)
16.6.1. Overview
16.6.2. SRC Analysis
16.7. Europe Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2030(US$ Bn)
16.7.1. Overview
16.7.2. SRC Analysis
16.8. Europe Solid Organ Transplant Immunosuppressant Market, by Country, 2017-2030 (US$ Bn)
16.8.1. Europe Solid Organ Transplant Immunosuppressant Market, by Country, 2022 Vs 2030 (in%)
16.8.2. UK
16.8.3. France
16.8.4. Germany
16.8.5. Italy
16.8.6. Spain
16.8.7. Benelux
16.8.8. Russia
16.8.9. Rest of Europe

17. Asia Pacific Solid Organ Transplant Immunosuppressant Market Analysis
17.1. Overview
17.1.1. Market Dynamics for Asia Pacific
17.1.1.1. Drivers
17.1.1.2. Restraints
17.1.1.3. Opportunities
17.1.1.4. Trends
17.2. Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2030(US$ Bn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2030(US$ Bn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2030(US$ Bn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2030(US$ Bn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2030(US$ Bn)
17.6.1. Overview
17.6.2. SRC Analysis
17.7. Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2030(US$ Bn)
17.7.1. Overview
17.7.2. SRC Analysis
17.8. Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Country, 2017-2030 (US$ Bn)
17.8.1. Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Country, 2022 Vs 2030 (in%)
17.8.2. China
17.8.3. Japan
17.8.4. India
17.8.5. South Korea
17.8.6. South East Asia
17.8.7. Rest of Asia Pacific

18. Latin America Solid Organ Transplant Immunosuppressant Market Analysis
18.1. Overview
18.1.1. Market Dynamics for Latin America
18.1.1.1. Drivers
18.1.1.2. Restraints
18.1.1.3. Opportunities
18.1.1.4. Trends
18.2. Latin America Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2030(US$ Bn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Latin America Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2030(US$ Bn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Latin America Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2030(US$ Bn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Latin America Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2030(US$ Bn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Latin America Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2030(US$ Bn)
18.6.1. Overview
18.6.2. SRC Analysis
18.7. Latin America Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2030(US$ Bn)
18.7.1. Overview
18.7.2. SRC Analysis
18.8. Latin America Solid Organ Transplant Immunosuppressant Market, by Country, 2017-2030 (US$ Bn)
18.8.1. Latin America Solid Organ Transplant Immunosuppressant Market, by Country, 2022 Vs 2030 (in%)
18.8.2. Brazil
18.8.3. Argentina
18.8.4. Rest of Latin America

19. Middle East Solid Organ Transplant Immunosuppressant Market Analysis
19.1. Overview
19.1.1. Market Dynamics for Middle East
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. Middle East Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2030(US$ Bn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. Middle East Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2030(US$ Bn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. Middle East Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2030(US$ Bn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. Middle East Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2030(US$ Bn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. Middle East Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2030(US$ Bn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. Middle East Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2030(US$ Bn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. Middle East Solid Organ Transplant Immunosuppressant Market, by Country, 2017-2030 (US$ Bn)
19.8.1. Middle East Solid Organ Transplant Immunosuppressant Market, by Country, 2022 Vs 2030 (in%)
19.8.2. UAE
19.8.3. Saudi Arabia
19.8.4. Rest of Middle East

20. Africa Solid Organ Transplant Immunosuppressant Market Analysis
20.1. Overview
20.1.1. Market Dynamics for Africa
20.1.1.1. Drivers
20.1.1.2. Restraints
20.1.1.3. Opportunities
20.1.1.4. Trends
20.2. Africa Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2030(US$ Bn)
20.2.1. Overview
20.2.2. SRC Analysis
20.3. Africa Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2030(US$ Bn)
20.3.1. Overview
20.3.2. SRC Analysis
20.4. Africa Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2030(US$ Bn)
20.4.1. Overview
20.4.2. SRC Analysis
20.5. Africa Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2030(US$ Bn)
20.5.1. Overview
20.5.2. SRC Analysis
20.6. Africa Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2030(US$ Bn)
20.6.1. Overview
20.6.2. SRC Analysis
20.7. Africa Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2030(US$ Bn)
20.7.1. Overview
20.7.2. SRC Analysis
20.8. Africa Solid Organ Transplant Immunosuppressant Market, by Country, 2017-2030 (US$ Bn)
20.8.1. Africa Solid Organ Transplant Immunosuppressant Market, by Country, 2022 Vs 2030 (in%)
20.8.2. South Africa
20.8.3. Egypt
20.8.4. Rest of Africa

21. Company Profiles
21.1. Novartis
21.1.1. Company Overview
21.1.2. Products/Services Portfolio
21.1.3. Geographical Presence
21.1.4. SWOT Analysis
21.1.5. Financial Summary
21.1.5.1. Market Revenue and Net Profit (2019-2022)
21.1.5.2. Business Segment Revenue Analysis
21.1.5.3. Geographical Revenue Analysis
21.2. Wyeth (Pfizer)
21.3. Genzyme (Sanofi)
21.4. Roche
21.5. Astellas Pharma
21.6. GlaxoSmithKline
21.7. Bristol-Myers Squibb Company
21.8. Veloxis Pharmaceuticals A/S
21.9. Belcher Pharmaceuticals LLC
21.10. Mylan Laboratories, Inc.
21.11. Others

22. Research Methodology
22.1. Research Methodology
22.2. Phase I – Secondary Research
22.3. Phase II – Data Modelling
22.3.1. Company Share Analysis Model
22.3.2. Revenue Based Modelling
22.4. Phase III – Primary Research
22.5. Research Limitations
22.5.1. Assumptions

List of Figures
FIG. 1 Global Solid Organ Transplant Immunosuppressant Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Solid Organ Transplant Immunosuppressant Market Segmentation
FIG. 4 Global Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2022 (US$ Bn)
FIG. 5 Global Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2022 (US$ Bn)
FIG. 6 Global Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2022 (US$ Bn)
FIG. 7 Global Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2022 (US$ Bn)
FIG. 8 Global Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2022 (US$ Bn)
FIG. 9 Global Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2022 (US$ Bn)
FIG. 10 Global Solid Organ Transplant Immunosuppressant Market, by Geography, 2022 (US$ Bn)
FIG. 11 Attractive Investment Proposition, by Drug Class, 2022
FIG. 12 Attractive Investment Proposition, by Organ Transplant Type, 2022
FIG. 13 Attractive Investment Proposition, by Patient Age, 2022
FIG. 14 Attractive Investment Proposition, by Treatment Duration, 2022
FIG. 15 Attractive Investment Proposition, by Distribution Channels, 2022
FIG. 16 Attractive Investment Proposition, by Dosage Forms, 2022
FIG. 17 Attractive Investment Proposition, by Geography, 2022
FIG. 18 Global Market Share Analysis of Key Solid Organ Transplant Immunosuppressant Market Manufacturers, 2022
FIG. 19 Global Market Positioning of Key Solid Organ Transplant Immunosuppressant Market Manufacturers, 2022
FIG. 20 Global Solid Organ Transplant Immunosuppressant Market Value Contribution, By Drug Class, 2022 & 2030 (Value %)
FIG. 21 Global Solid Organ Transplant Immunosuppressant Market, by Calcineurin Inhibitors, Value, 2017-2030 (US$ Bn)
FIG. 22 Global Solid Organ Transplant Immunosuppressant Market, by Antiproliferative Agents, Value, 2017-2030 (US$ Bn)
FIG. 23 Global Solid Organ Transplant Immunosuppressant Market, by mTOR Inhibitors, Value, 2017-2030 (US$ Bn)
FIG. 24 Global Solid Organ Transplant Immunosuppressant Market, by Corticosteroids, Value, 2017-2030 (US$ Bn)
FIG. 25 Global Solid Organ Transplant Immunosuppressant Market, by Induction Agents, Value, 2017-2030 (US$ Bn)
FIG. 26 Global Solid Organ Transplant Immunosuppressant Market Value Contribution, By Organ Transplant Type, 2022 & 2030 (Value %)
FIG. 27 Global Solid Organ Transplant Immunosuppressant Market, by Kidney Transplant, Value, 2017-2030 (US$ Bn)
FIG. 28 Global Solid Organ Transplant Immunosuppressant Market, by Liver Transplant, Value, 2017-2030 (US$ Bn)
FIG. 29 Global Solid Organ Transplant Immunosuppressant Market, by Heart Transplant, Value, 2017-2030 (US$ Bn)
FIG. 30 Global Solid Organ Transplant Immunosuppressant Market, by Lung Transplant, Value, 2017-2030 (US$ Bn)
FIG. 31 Global Solid Organ Transplant Immunosuppressant Market, by Pancreas Transplant, Value, 2017-2030 (US$ Bn)
FIG. 32 Global Solid Organ Transplant Immunosuppressant Market Value Contribution, By Patient Age, 2022 & 2030 (Value %)
FIG. 33 Global Solid Organ Transplant Immunosuppressant Market, by Pediatric Patients, Value, 2017-2030 (US$ Bn)
FIG. 34 Global Solid Organ Transplant Immunosuppressant Market, by Adult Patients, Value, 2017-2030 (US$ Bn)
FIG. 35 Global Solid Organ Transplant Immunosuppressant Market Value Contribution, By Treatment Duration, 2022 & 2030 (Value %)
FIG. 36 Global Solid Organ Transplant Immunosuppressant Market, by Short-Term Treatment (Induction Phase), Value, 2017-2030 (US$ Bn)
FIG. 37 Global Solid Organ Transplant Immunosuppressant Market, by Long-Term Maintenance Treatment, Value, 2017-2030 (US$ Bn)
FIG. 38 Global Solid Organ Transplant Immunosuppressant Market Value Contribution, By Distribution Channels, 2022 & 2030 (Value %)
FIG. 39 Global Solid Organ Transplant Immunosuppressant Market, by Hospitals and Clinics, Value, 2017-2030 (US$ Bn)
FIG. 40 Global Solid Organ Transplant Immunosuppressant Market, by Retail Pharmacies, Value, 2017-2030 (US$ Bn)
FIG. 41 Global Solid Organ Transplant Immunosuppressant Market, by Specialty Pharmacies, Value, 2017-2030 (US$ Bn)
FIG. 42 Global Solid Organ Transplant Immunosuppressant Market Value Contribution, By Dosage Forms, 2022 & 2030 (Value %)
FIG. 43 Global Solid Organ Transplant Immunosuppressant Market, by Oral Tablets/Capsules, Value, 2017-2030 (US$ Bn)
FIG. 44 Global Solid Organ Transplant Immunosuppressant Market, by Intravenous (IV) Formulations, Value, 2017-2030 (US$ Bn)
FIG. 45 North America Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 46 U.S. Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 47 Canada Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 48 Mexico Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 49 Europe Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 50 Germany Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 51 France Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 52 U.K. Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 53 Italy Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 54 Spain Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 55 Benelux Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 56 Russia Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 57 Rest of Europe Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 58 Asia Pacific Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 59 China Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 60 Japan Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 61 India Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 62 South Korea Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 63 South-East Asia Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 64 Rest of Asia Pacific Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 65 Latin America Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 66 Brazil Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 67 Argentina Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 68 Rest of Latin America Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 69 Middle East Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 70 UAE Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 71 Saudi Arabia Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 72 Rest of Middle East Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 73 Africa Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 74 South Africa Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 75 Egypt Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)
FIG. 76 Rest of Africa Solid Organ Transplant Immunosuppressant Market, 2017-2030 (US$ Bn)

 

List of Tables
TABLE 1 Market Snapshot: Global Solid Organ Transplant Immunosuppressant Market
TABLE 2 Global Solid Organ Transplant Immunosuppressant Market: Market Drivers Impact Analysis
TABLE 3 Global Solid Organ Transplant Immunosuppressant Market: Market Restraints Impact Analysis
TABLE 4 Global Solid Organ Transplant Immunosuppressant Market, by Competitive Benchmarking, 2022
TABLE 5 Global Solid Organ Transplant Immunosuppressant Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Solid Organ Transplant Immunosuppressant Market, by Key Strategies Analysis, 2022
TABLE 7 Global Solid Organ Transplant Immunosuppressant Market, by Calcineurin Inhibitors, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Solid Organ Transplant Immunosuppressant Market, by Calcineurin Inhibitors, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Solid Organ Transplant Immunosuppressant Market, by Antiproliferative Agents, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Solid Organ Transplant Immunosuppressant Market, by Antiproliferative Agents, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Solid Organ Transplant Immunosuppressant Market, by mTOR Inhibitors, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Solid Organ Transplant Immunosuppressant Market, by mTOR Inhibitors, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Solid Organ Transplant Immunosuppressant Market, by Corticosteroids, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Solid Organ Transplant Immunosuppressant Market, by Corticosteroids, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Solid Organ Transplant Immunosuppressant Market, by Induction Agents, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Solid Organ Transplant Immunosuppressant Market, by Induction Agents, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Solid Organ Transplant Immunosuppressant Market, by Kidney Transplant, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Solid Organ Transplant Immunosuppressant Market, by Kidney Transplant, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Solid Organ Transplant Immunosuppressant Market, by Liver Transplant, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Solid Organ Transplant Immunosuppressant Market, by Liver Transplant, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Solid Organ Transplant Immunosuppressant Market, by Heart Transplant, By Region, 2017-2022 (US$ Bn)
TABLE 22 Global Solid Organ Transplant Immunosuppressant Market, by Heart Transplant, By Region, 2023-2030 (US$ Bn)
TABLE 23 Global Solid Organ Transplant Immunosuppressant Market, by Lung Transplant, By Region, 2017-2022 (US$ Bn)
TABLE 24 Global Solid Organ Transplant Immunosuppressant Market, by Lung Transplant, By Region, 2023-2030 (US$ Bn)
TABLE 25 Global Solid Organ Transplant Immunosuppressant Market, by Pancreas Transplant, By Region, 2017-2022 (US$ Bn)
TABLE 26 Global Solid Organ Transplant Immunosuppressant Market, by Pancreas Transplant, By Region, 2023-2030 (US$ Bn)
TABLE 27 Global Solid Organ Transplant Immunosuppressant Market, by Pediatric Patients, By Region, 2017-2022 (US$ Bn)
TABLE 28 Global Solid Organ Transplant Immunosuppressant Market, by Pediatric Patients, By Region, 2023-2030 (US$ Bn)
TABLE 29 Global Solid Organ Transplant Immunosuppressant Market, by Adult Patients, By Region, 2017-2022 (US$ Bn)
TABLE 30 Global Solid Organ Transplant Immunosuppressant Market, by Adult Patients, By Region, 2023-2030 (US$ Bn)
TABLE 31 Global Solid Organ Transplant Immunosuppressant Market, by Short-Term Treatment (Induction Phase), By Region, 2017-2022 (US$ Bn)
TABLE 32 Global Solid Organ Transplant Immunosuppressant Market, by Short-Term Treatment (Induction Phase), By Region, 2023-2030 (US$ Bn)
TABLE 33 Global Solid Organ Transplant Immunosuppressant Market, by Long-Term Maintenance Treatment, By Region, 2017-2022 (US$ Bn)
TABLE 34 Global Solid Organ Transplant Immunosuppressant Market, by Long-Term Maintenance Treatment, By Region, 2023-2030 (US$ Bn)
TABLE 35 Global Solid Organ Transplant Immunosuppressant Market, by Hospitals and Clinics, By Region, 2017-2022 (US$ Bn)
TABLE 36 Global Solid Organ Transplant Immunosuppressant Market, by Hospitals and Clinics, By Region, 2023-2030 (US$ Bn)
TABLE 37 Global Solid Organ Transplant Immunosuppressant Market, by Retail Pharmacies, By Region, 2017-2022 (US$ Bn)
TABLE 38 Global Solid Organ Transplant Immunosuppressant Market, by Retail Pharmacies, By Region, 2023-2030 (US$ Bn)
TABLE 39 Global Solid Organ Transplant Immunosuppressant Market, by Specialty Pharmacies, By Region, 2017-2022 (US$ Bn)
TABLE 40 Global Solid Organ Transplant Immunosuppressant Market, by Specialty Pharmacies, By Region, 2023-2030 (US$ Bn)
TABLE 41 Global Solid Organ Transplant Immunosuppressant Market, by Oral Tablets/Capsules, By Region, 2017-2022 (US$ Bn)
TABLE 42 Global Solid Organ Transplant Immunosuppressant Market, by Oral Tablets/Capsules, By Region, 2023-2030 (US$ Bn)
TABLE 43 Global Solid Organ Transplant Immunosuppressant Market, by Intravenous (IV) Formulations, By Region, 2017-2022 (US$ Bn)
TABLE 44 Global Solid Organ Transplant Immunosuppressant Market, by Intravenous (IV) Formulations, By Region, 2023-2030 (US$ Bn)
TABLE 45 Global Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 46 Global Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 47 Global Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 48 Global Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 49 Global Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 50 Global Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 51 Global Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 52 Global Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 53 Global Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 54 Global Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 55 Global Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 56 Global Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 57 Global Solid Organ Transplant Immunosuppressant Market, by Region, 2017-2022 (US$ Bn)
TABLE 58 Global Solid Organ Transplant Immunosuppressant Market, by Region, 2023-2030 (US$ Bn)
TABLE 59 North America Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 60 North America Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 61 North America Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 62 North America Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 63 North America Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 64 North America Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 65 North America Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 66 North America Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 67 North America Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 68 North America Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 69 North America Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 70 North America Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 71 North America Solid Organ Transplant Immunosuppressant Market, by Country, 2017-2022 (US$ Bn)
TABLE 72 North America Solid Organ Transplant Immunosuppressant Market, by Country, 2023-2030 (US$ Bn)
TABLE 73 United States Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 74 United States Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 75 United States Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 76 United States Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 77 United States Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 78 United States Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 79 United States Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 80 United States Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 81 United States Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 82 United States Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 83 United States Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 84 United States Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 85 Canada Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 86 Canada Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 87 Canada Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 88 Canada Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 89 Canada Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 90 Canada Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 91 Canada Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 92 Canada Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 93 Canada Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 94 Canada Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 95 Canada Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 96 Canada Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 97 Mexico Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 98 Mexico Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 99 Mexico Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 100 Mexico Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 101 Mexico Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 102 Mexico Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 103 Mexico Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 104 Mexico Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 105 Mexico Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 106 Mexico Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 107 Mexico Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 108 Mexico Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 109 Europe Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 110 Europe Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 111 Europe Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 112 Europe Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 113 Europe Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 114 Europe Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 115 Europe Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 116 Europe Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 117 Europe Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 118 Europe Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 119 Europe Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 120 Europe Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 121 Europe Solid Organ Transplant Immunosuppressant Market, by Country, 2017-2022 (US$ Bn)
TABLE 122 Europe Solid Organ Transplant Immunosuppressant Market, by Country, 2023-2030 (US$ Bn)
TABLE 123 Germany Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 124 Germany Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 125 Germany Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 126 Germany Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 127 Germany Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 128 Germany Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 129 Germany Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 130 Germany Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 131 Germany Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 132 Germany Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 133 Germany Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 134 Germany Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 135 France Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 136 France Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 137 France Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 138 France Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 139 France Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 140 France Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 141 France Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 142 France Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 143 France Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 144 France Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 145 France Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 146 France Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 147 United Kingdom Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 148 United Kingdom Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 149 United Kingdom Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 150 United Kingdom Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 151 United Kingdom Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 152 United Kingdom Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 153 United Kingdom Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 154 United Kingdom Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 155 United Kingdom Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 156 United Kingdom Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 157 United Kingdom Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 158 United Kingdom Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 159 Italy Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 160 Italy Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 161 Italy Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 162 Italy Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 163 Italy Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 164 Italy Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 165 Italy Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 166 Italy Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 167 Italy Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 168 Italy Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 169 Italy Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 170 Italy Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 171 Spain Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 172 Spain Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 173 Spain Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 174 Spain Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 175 Spain Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 176 Spain Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 177 Spain Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 178 Spain Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 179 Spain Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 180 Spain Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 181 Spain Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 182 Spain Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 183 Benelux Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 184 Benelux Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 185 Benelux Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 186 Benelux Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 187 Benelux Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 188 Benelux Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 189 Benelux Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 190 Benelux Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 191 Benelux Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 192 Benelux Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 193 Benelux Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 194 Benelux Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 195 Russia Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 196 Russia Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 197 Russia Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 198 Russia Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 199 Russia Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 200 Russia Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 201 Russia Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 202 Russia Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 203 Russia Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 204 Russia Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 205 Russia Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 206 Russia Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 207 Rest of Europe Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 208 Rest of Europe Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 209 Rest of Europe Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 210 Rest of Europe Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 211 Rest of Europe Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 212 Rest of Europe Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 213 Rest of Europe Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 214 Rest of Europe Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 215 Rest of Europe Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 216 Rest of Europe Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 217 Rest of Europe Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 218 Rest of Europe Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 219 Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 220 Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 221 Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 222 Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 223 Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 224 Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 225 Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 226 Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 227 Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 228 Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 229 Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 230 Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 231 China Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 232 China Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 233 China Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 234 China Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 235 China Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 236 China Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 237 China Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 238 China Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 239 China Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 240 China Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 241 China Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 242 China Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 243 Japan Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 244 Japan Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 245 Japan Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 246 Japan Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 247 Japan Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 248 Japan Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 249 Japan Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 250 Japan Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 251 Japan Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 252 Japan Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 253 Japan Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 254 Japan Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 255 India Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 256 India Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 257 India Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 258 India Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 259 India Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 260 India Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 261 India Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 262 India Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 263 India Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 264 India Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 265 India Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 266 India Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 267 South Korea Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 268 South Korea Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 269 South Korea Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 270 South Korea Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 271 South Korea Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 272 South Korea Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 273 South Korea Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 274 South Korea Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 275 South Korea Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 276 South Korea Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 277 South Korea Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 278 South Korea Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 279 South-East Asia Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 280 South-East Asia Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 281 South-East Asia Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 282 South-East Asia Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 283 South-East Asia Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 284 South-East Asia Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 285 South-East Asia Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 286 South-East Asia Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 287 South-East Asia Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 288 South-East Asia Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 289 South-East Asia Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 290 South-East Asia Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 291 Rest of Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 292 Rest of Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 293 Rest of Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 294 Rest of Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 295 Rest of Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 296 Rest of Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 297 Rest of Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 298 Rest of Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 299 Rest of Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 300 Rest of Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 301 Rest of Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 302 Rest of Asia Pacific Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 303 Latin America Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 304 Latin America Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 305 Latin America Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 306 Latin America Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 307 Latin America Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 308 Latin America Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 309 Latin America Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 310 Latin America Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 311 Latin America Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 312 Latin America Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 313 Latin America Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 314 Latin America Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 315 Brazil Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 316 Brazil Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 317 Brazil Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 318 Brazil Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 319 Brazil Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 320 Brazil Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 321 Brazil Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 322 Brazil Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 323 Brazil Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 324 Brazil Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 325 Brazil Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 326 Brazil Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 327 Argentina Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 328 Argentina Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 329 Argentina Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 330 Argentina Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 331 Argentina Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 332 Argentina Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 333 Argentina Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 334 Argentina Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 335 Argentina Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 336 Argentina Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 337 Argentina Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 338 Argentina Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 339 Rest of Latin America Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 340 Rest of Latin America Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 341 Rest of Latin America Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 342 Rest of Latin America Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 343 Rest of Latin America Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 344 Rest of Latin America Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 345 Rest of Latin America Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 346 Rest of Latin America Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 347 Rest of Latin America Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 348 Rest of Latin America Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 349 Rest of Latin America Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 350 Rest of Latin America Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 351 Middle East Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 352 Middle East Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 353 Middle East Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 354 Middle East Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 355 Middle East Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 356 Middle East Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 357 Middle East Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 358 Middle East Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 359 Middle East Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 360 Middle East Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 361 Middle East Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 362 Middle East Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 363 UAE Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 364 UAE Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 365 UAE Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 366 UAE Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 367 UAE Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 368 UAE Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 369 UAE Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 370 UAE Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 371 UAE Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 372 UAE Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 373 UAE Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 374 UAE Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 375 Saudi Arabia Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 376 Saudi Arabia Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 377 Saudi Arabia Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 378 Saudi Arabia Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 379 Saudi Arabia Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 380 Saudi Arabia Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 381 Saudi Arabia Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 382 Saudi Arabia Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 383 Saudi Arabia Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 384 Saudi Arabia Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 385 Saudi Arabia Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 386 Saudi Arabia Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 387 Rest of Middle East Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 388 Rest of Middle East Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 389 Rest of Middle East Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 390 Rest of Middle East Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 391 Rest of Middle East Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 392 Rest of Middle East Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 393 Rest of Middle East Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 394 Rest of Middle East Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 395 Rest of Middle East Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 396 Rest of Middle East Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 397 Rest of Middle East Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 398 Rest of Middle East Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 399 Africa Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 400 Africa Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 401 Africa Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 402 Africa Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 403 Africa Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 404 Africa Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 405 Africa Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 406 Africa Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 407 Africa Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 408 Africa Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 409 Africa Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 410 Africa Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 411 South Africa Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 412 South Africa Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 413 South Africa Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 414 South Africa Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 415 South Africa Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 416 South Africa Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 417 South Africa Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 418 South Africa Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 419 South Africa Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 420 South Africa Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 421 South Africa Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 422 South Africa Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 423 Egypt Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 424 Egypt Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 425 Egypt Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 426 Egypt Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 427 Egypt Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 428 Egypt Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 429 Egypt Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 430 Egypt Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 431 Egypt Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 432 Egypt Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 433 Egypt Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 434 Egypt Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)
TABLE 435 Rest of Africa Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 436 Rest of Africa Solid Organ Transplant Immunosuppressant Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 437 Rest of Africa Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2017-2022 (US$ Bn)
TABLE 438 Rest of Africa Solid Organ Transplant Immunosuppressant Market, by Organ Transplant Type, 2023-2030 (US$ Bn)
TABLE 439 Rest of Africa Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2017-2022 (US$ Bn)
TABLE 440 Rest of Africa Solid Organ Transplant Immunosuppressant Market, by Patient Age, 2023-2030 (US$ Bn)
TABLE 441 Rest of Africa Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2017-2022 (US$ Bn)
TABLE 442 Rest of Africa Solid Organ Transplant Immunosuppressant Market, by Treatment Duration, 2023-2030 (US$ Bn)
TABLE 443 Rest of Africa Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2017-2022 (US$ Bn)
TABLE 444 Rest of Africa Solid Organ Transplant Immunosuppressant Market, by Distribution Channels, 2023-2030 (US$ Bn)
TABLE 445 Rest of Africa Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2017-2022 (US$ Bn)
TABLE 446 Rest of Africa Solid Organ Transplant Immunosuppressant Market, by Dosage Forms, 2023-2030 (US$ Bn)

Frequently Asked Questions

How big is the global market for solid organ transplant immunosuppressants right now?

In 2022, the solid organ transplant immunosuppressant market was estimated to be worth USD 1.3 billion.

What is the solid organ transplant immunosuppressant market’s anticipated growth rate from 2023 to 2030?

The solid organ transplant immunosuppressant market is anticipated to increase at a CAGR of 6.80% from 2023 to 2030, reaching USD 2.20 billion in 2030.

In terms of drug class, which market category is in the lead?

The most important common drug class is calcineurin inhibitors.

Which segment is leading the market in terms of organ transplant type?

Regarding organ transplant type, kidney transplants are the most widespread.

Which distribution channel segment is anticipated to have the highest CAGR throughout the forecast period?

During the forecast period, the segment of retail pharmacies is anticipated to have the greatest CAGR.

In which region is the market for solid organ transplant immunosuppressants expanding?

North America dominated the solid organ transplant immunosuppressant market.

Who are the key participants in the market for solid organ transplant immunosuppressants globally?

The top players include Novartis, Wyeth (Pfizer), Genzyme (Sanofi), Roche, Astellas Pharma, GlaxoSmithKline, Bristol-Myers Squibb Company, Veloxis Pharmaceuticals A/S, Belcher Pharmaceuticals LLC, Mylan Laboratories, Inc., and others.

What are the main market factors driving the solid organ transplant immunosuppressant sector?

Increasing organ transplantation rates, a growing aging population, advancements in transplantation procedures, and patient support programs are some of the major reasons boosting the growth of the solid organ transplant immunosuppressant market.

What main market challenges prevent the solid organ transplant immunosuppressant sector from growing?

The constraints limiting the expansion of the solid organ transplant immunosuppressant market include the lack of organs, issues associated with immunosuppression, medication non-adherence, immunological challenges, and the cost of immunosuppressant drugs.

What are the main market opportunities for the solid organ transplant immunosuppressant sector?

The advancements in regenerative medicine, the adoption of patient-centered care models, and the growing use of telehealth and remote monitoring technology are the main opportunities for expanding the solid organ transplant immunosuppressant market.

Related Reports By Keyword

Solid State Relay Market

Published:
Report ID: 42637

Solid Oxide Fuel Cell (SOFC) Market

Published:
Report ID: 10631

Oral Solid Dosage Manufacturing Market

Published:
Report ID: 41090

Semi-Solid Dosage Forms Contract Manufacturing Market

Published:
Report ID: 33462

Vietnam Oral Solid Dosage Contract Manufacturing Market

Published:
Report ID: 32341

Europe Oral Solid Dosage Contract Manufacturing Market

Published:
Report ID: 32265

Asia Pacific Oral Solid Dosage Contract Manufacturing Market

Published:
Report ID: 32191

Oral Solid Dosage Contract Manufacturing Market

Published:
Report ID: 20095

Electric Vehicle Solid State Battery Market

Published:
Report ID: 16153

Related Reports

Medical Robotic System Market

Published:
Report ID: 54425

Healthcare Informatics Market

Published:
Report ID: 54414

Healthcare Distribution Market

Published:
Report ID: 54409

Healthcare Consumables Market

Published:
Report ID: 54403

Life Science Tools Market

Published:
Report ID: 54330

High Potency Active Pharmaceutical Ingredients Market

Published:
Report ID: 54268

Stroke Diagnostics Market

Published:
Report ID: 54305

Medical Billing Market

Published:
Report ID: 54117

Live Attenuated Vaccines Market

Published:
Report ID: 54114

Liquid Chromatography Instruments Market

Published:
Report ID: 54111

Healthcare Enterprise Software Market

Published:
Report ID: 54079

Physical Therapy Rehabilitation Solutions Market

Published:
Report ID: 54011

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$3699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$4699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$6699

Request Free Sample

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207

support

24/7 Research Support

sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

Get Methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN
Request Free Sample